What You Should Know:
- A glimmer of hope shines through for hospitals, according to November data from Kaufman Hall's National Hospital Flash Report points to ongoing stabilization and even growth.
- While the scars of the pandemic and economic challenges remain, key indicators suggest gradual recovery, with operating margins edging up and revenue streams climbing.
Margins on the Rise, Though Gap Between Performers Persists
The median calendar year-to-date operating margin index for
Read More
Digital Health Funding Plunges in 2023, Setting Stage for 2024 Reckoning
What You Should Know:
- The year 2023 saw a stark shift in the digital health funding landscape, according to Rock Health’s annual year-end digital health funding report. Gone were the days of exuberant funding rounds and endless optimism.
- Instead, we witnessed a contraction, with venture capital drying up and startups scrambling to stay afloat. But amidst the turbulence, there were also signs of resilience, innovation, and a necessary course correction.
2023: A Year of Transition and
Read More
Mayo Clinic, Techcyte Partner to Create AI-Powered Pathology Platform
What You Should Know:
- Mayo Clinic Platformv and Techcyte have joined forces to revolutionize the field of pathology by creating a digital pathology platform. This platform aims to pioneer the next generation of pathology services through an open, AI-driven solution, enhancing treatment, efficiency, and accuracy globally.
- By enabling healthcare organizations to economically digitize their pathology practices, the platform integrates innovative technical and AI workflow
Read More
Arineta Cardio Imaging Welcomes New CEO Doug Ryan
What You Should Know:
- Arineta Cardio Imaging, a pioneer in cutting-edge cardiovascular imaging solutions, has appointed seasoned medical device leader Doug Ryan as its new CEO.
- Ryan brings 30 years of expertise in building business infrastructure and crafting market strategies for global healthcare giants, poised to propel Arineta to new heights in the fight against cardiovascular disease.
Proven Track Record of Success
Prior to joining Arineta, Ryan held pivotal leadership
Read More
Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection
What You Should Know:
- Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
- Under the terms of the agreement, Veracyte will pay $70 million in Veracyte shares at closing, and up to an additional $25 million based on the achievement of future performance milestones over the next two years, payable in Veracyte shares or cash at Veracyte’s election.
- This strategic move positions Veracyte to
Read More
Cityblock Expands Access for High-Risk Medicaid Members in Ohio
What You Should Know:
- Buckeye Health Plan and Cityblock are teaming up to provide integrated, community-based care to approximately 10,000 underserved Medicaid recipients in the Cleveland-Akron-Canton area.
- The strategic partnership promises to redefine healthcare delivery for vulnerable communities, prioritizing whole-person health and tackling barriers to access in Ohio.
Building Bridges, Improving Outcomes
Buckeye is a leading Ohio Medicaid managed care plan serving over
Read More
Amazon Unveils Health Condition Programs Making Chronic Condition Management Easier
What You Should Know:
- Amazon launches its new Health Condition Programs to simplify access to digital health benefits offered by insurance plans and employers.
- By partnering with companies like Omada Health, Amazon brings awareness and enrollment options directly to patients where they're already looking for health information. This collaboration targets conditions like diabetes prevention, diabetes management, and hypertension, impacting millions of Americans.
How Amazon’s Health
Read More
Amgen Builds Generative AI Models for Human Data Analysis and Drug Discovery
What You Should Know:
- Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja.
- The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after the Norse goddess of prediction, to accelerate drug discovery and development through AI-powered insights from one of the world's largest human datasets.
Advance Drug Discovery Using NVIDIA DGX SuperPOD-Powered Insight
Human Diversity Atlas: Freyja will map the landscape
Read More
Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US
What You Should Know:
- Tandem Diabetes Care and Abbott have joined forces to bring the first automated insulin delivery (AID) system in the US compatible with Abbott's latest FreeStyle Libre 2 Plus sensor.
- The integration brings the benefits of advanced closed-loop technology to millions of Americans living with diabetes, helping them achieve better blood sugar control and manage their condition with greater ease.
Seamless Integration for Precise Control:
The t:slim X2 insulin
Read More
Socially Determined and Uber Health Partner to Bridge Healthcare and Social Needs
What You Should Know:
- Socially Determined, the leading social risk analytics company, and Uber Health, the healthcare platform for seamless benefit coordination, have announced a partnership to empower individuals and families facing common healthcare challenges.
- The strategic joint effort focuses on connecting vulnerable Medicaid, Medicare Advantage, and commercially insured beneficiaries with critical supplemental benefits like transportation, food delivery, and medication
Read More
